Search alternatives:
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
level decrease » levels decreased (Expand Search), level increased (Expand Search), level disease (Expand Search)
Showing 661 - 680 results of 10,974 for search 'significant ((((level decrease) OR (teer decrease))) OR (((mean decrease) OR (greater decrease))))', query time: 0.59s Refine Results
  1. 661
    Expression level (2<sup>-ΔCq</sup>) of microRNA in the cerebellum of control, pinealectomized (PINX) and melatonin-treated (PINX-MEL) rats.

    Expression level (2<sup>-ΔCq</sup>) of microRNA in the cerebellum of control, pinealectomized (PINX) and melatonin-treated (PINX-MEL) rats. by Mísia Helena da Silva Ferro (20623666)

    Published 2025
    Save to List
    Saved in:
  2. 662
    Expression level (2<sup>-ΔCq</sup>) of microRNA in the sperm of control, pinealectomized (PINX) and melatonin-treated (PINX-MEL) rats.

    Expression level (2<sup>-ΔCq</sup>) of microRNA in the sperm of control, pinealectomized (PINX) and melatonin-treated (PINX-MEL) rats. by Mísia Helena da Silva Ferro (20623666)

    Published 2025
    Save to List
    Saved in:
  3. 663
    Expression level (2<sup>-ΔCq</sup>) of microRNA in the hypothalamus of control, pinealectomized (PINX) and melatonin-treated (PINX-MEL) rats.

    Expression level (2<sup>-ΔCq</sup>) of microRNA in the hypothalamus of control, pinealectomized (PINX) and melatonin-treated (PINX-MEL) rats. by Mísia Helena da Silva Ferro (20623666)

    Published 2025
    Save to List
    Saved in:
  4. 664
    Fig 4 -

    Fig 4 - by Leena Inkilä (20614460)

    Published 2025
    Save to List
    Saved in:
  5. 665
    Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group.

    Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 666
    Relative expression levels in TNF-α, IL-6, and p53 in co-culture and CM treatment of hypoxic and normoxic PANC-1 cells with CD8+ T-cells.

    Relative expression levels in TNF-α, IL-6, and p53 in co-culture and CM treatment of hypoxic and normoxic PANC-1 cells with CD8+ T-cells. by Eiman Abdo (20642254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 667
    Maximum likelihood estimates of trans-log mean stochastic function.

    Maximum likelihood estimates of trans-log mean stochastic function. by James Anaba Akolgo (14129379)

    Published 2025
    Save to List
    Saved in:
  8. 668
    Demographic data of female participants (n = 30).

    Demographic data of female participants (n = 30). by Vanessa Wellauer (18408477)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 669
    Raw data used for statistical analysis.

    Raw data used for statistical analysis. by Vanessa Wellauer (18408477)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 670
    CONSORT flowchart of participants.

    CONSORT flowchart of participants. by Vanessa Wellauer (18408477)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 671
    Craniocaudal impulses of fore- and hindlimbs at three bar heights during take-off.

    Craniocaudal impulses of fore- and hindlimbs at three bar heights during take-off. by Leena Inkilä (20614460)

    Published 2025
    Save to List
    Saved in:
  12. 672
    Map with color coding showing the relative risk of loss at the regional level for each country in Sub-Saharan Africa.

    Map with color coding showing the relative risk of loss at the regional level for each country in Sub-Saharan Africa. by Beatrice T. Nganso (4114768)

    Published 2025
    Save to List
    Saved in:
  13. 673
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 674
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 675
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 676
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 677
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 678
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 679
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 680
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: